SpectraWAVE’s HyperVue Intravascular Imaging System Approved by FDA
SpectraWAVE, a leading medical device company, has recently announced that its HyperVue Intravascular Imaging System has been approved by the US Food and Drug Administration (FDA). This groundbreaking technology is designed to provide physicians with an unprecedented level of visibility and accuracy when performing intravascular procedures.The HyperVue system is a combination of an advanced imaging catheter and a specialized imaging console. The catheter is inserted into the patient’s artery or vein and then guided through the vascular system. As it moves, the catheter takes high-resolution images of the vessel walls